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Should research fraud be a crime?
Zulfiqar A Bhutta says that criminal sanctions are necessary to deter growing deliberate research
misconduct, which can ultimately harm patients. Julian Crane disagrees: he doubts that sanctions
will have any deterrent effect and worries that criminalisation would undermine trust
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Yes—Zulfiqar A Bhutta
The fact that research fraud is common and possibly on the rise
globally isn’t news any more. A review of all 2047 retracted
biomedical research articles indexed by PubMed up to 3 May
2012 found that 67.4% of retractions were attributable to
scientific misconduct, including fraud or suspected fraud
(43.4%), duplicate publication (14.2%), and plagiarism (9.8%).1
Other assessments indicate that the number of articles retracted
a year increased 19-fold from 2001 to 2010, and the increase
was still 11-fold after repeat offenders were excluded and growth
of the literature had been adjusted for.2
The typology of research malfeasance varies, from sloppy
research to outright deliberate fraud. Most serious research fraud
relates to fabrication, falsification, and plagiarism.3 Estimates
of prevalence may yet be conservative. In a meta-analysis of
survey data, Fanelli suggested that 2% of all scientists admitted
to falsifying, fabricating, or modifying data at least once.4 The
scale of research fraud ranges from individual high profile cases,
such as in recent stem cell research from Korea and Japan,5 6 to
documented fraud by the drug industry, such as suppression of
paroxetine safety data by GlaxoSmithKline.7 This last case
included selective reporting or non-disclosure of critical
information on safety as well as falsification of data. Similar
charges were proved against the Indian generics manufacturer
Ranbaxy, which was subsequently fined $500m (£290m; €370m)
for data falsification after its global head of research and
portfolio management turned whistleblower.8
The consequences of research fraud on human health and clinical
practice can be huge. The damage to global vaccination coverage
caused by the fraudulent and discredited research by Andrew
Wakefield published 16 years ago and finally formally retracted
by the Lancet in 2010 has been incalculable.9 Yet he lives a free
man in Texas, raking in money from various support groups.
Fraudulent studies on pain research by the anaesthetist Scott
Reuben influenced “evidence based” practice for years, with
inestimable harm to patients. He was sentenced to six months’
imprisonment,10 but criminal proceedings after serious research

fraud are relatively rare. It is usually dealt with at an institutional
level by measures such as retraction of the work, termination
of contracts, and academic shaming.

No adequate redress
Many opine that this is fair, given that research fraud may be
difficult to differentiate from incompetence, errors, bias, and
misunderstanding.11 However, evidence suggests that deliberate
fraud is prevalent. Data manipulation related to drug industry
research is often dealt with through massive fines and marketing
restrictions,12 but the code of conduct for investigating and
tackling flagrant research fraud in academic settings is much
less clear.
In most instances institutions and academic bodies do not follow
up on alleged or proved wrongdoing with criminal proceedings.
This may relate to the difficulty in establishing malfeasance
beyond doubt; in other cases it may relate to concerns of
reputational risk and consequences for the institution. There
may also be the consideration of avoiding prolonged and
expensive investigations. A recent assessment of 17 cases of
misconduct reported by the US Office of Research Integrity for
2000-05 found that each investigation cost between $116 000
and $2m.13

Current measures are not enough. Although many perpetrators
of research fraud never return to academic life; others may claw
their way back to active research. Even Hwang Woo-suk,5 who
was forced to resign as professor at Seoul National University
after his landmark papers on stem cell research were found to
be fraudulent, has been able to return to public and scientific
life. He has written more than 100 scientific publications since
his fall from grace in 2006, 40 in the past two years alone.

Notwithstanding the importance of preventive measures,
currently research fraud offers relatively little risk for potentially
great rewards,14 and the process for detecting research fraud is
also too dependent on chance detection or whistleblowers. While
medical journals and university research integrity bodies
continue to tighten up regular processes for oversight and
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preventive failsafe mechanisms, it is important to treat research
fraud no differently from financial and healthcare fraud. Global
healthcare fraud has been shown to account for 3-8% of an
estimated £2 trillion in total healthcare costs,15 and although the
potential costs of health research fraud are not known, the
human, social, and economic costs are likely considerable.

I can accept that there is a gradient of research misconduct. But
in cases where deliberate research fraud is proved after thorough
investigation, additional deterrence through punitive measures
such as criminal proceedings should be added to the repertoire
of measures available. Research misconduct is not just related
to instances of harmless manipulation of molecules and
chemicals in laboratory settings: its consequences on health and
society can be huge. It is time to regard such behaviour in the
same category as criminal fraud and deal with it accordingly.

No—Julian Crane
Trust lies at the heart of any collective human enterprise. The
current avalanche of contractual and legally enforced
accountability designed to replace it suggests that we have a
crisis of trust, or so claimed the philosopher Onora O’Neill at
the start of her 2002 Reith lectures.16 Trying to enforce
accountability by criminalising research fraud would not
improve trust—it would undermine it. No matter what criminal
sanctions are enacted there will always remain considerable
opportunity for deception by researchers that is much better
prevented by transparency in an appropriate institutional
environment.

Research fraud is perceived to be widespread and harmful, and
institutions are perceived to be unable or unwilling to police it.
Terminology is important, and the word “research” may
euphemistically soften the word “fraud.”17 One definition of
research misconduct is “behaviour by a researcher, intentional
or not, that falls short of good ethical and scientific standards.”18
But the former editor of The BMJ Richard Smith recently
defined research misconduct as “the gentlemanly phrase for
scientific fraud.”19
Few researchers (and many of the world’s great discoverers) at
some time in their career would not have fallen foul of the first
definition. So are we all fraudsters, albeit gentlemanly ones?
Before we try to codify laws under which researchers may be
investigated, arrested, and criminally charged we need to clarify
what we mean by misconduct and fraud.

Not such a big problem
Smith says that research misconduct is “terrifyingly common.”
Published retractions as a surrogate for misconduct have been
tracked since the 1970s and have recently been systematically
reviewed.1 Most retractions (67.4%) have resulted from proved
or suspected misconduct. PubMed has indexed more than 25
million abstracts since the 1940s, and the first retraction was
published in 1977, though there are likely to have been articles
that should have been retracted before the 1970s. There have
been 2047 published retractions since 1977.1 If we assume that
67%, or 1371, are for misconduct then one in every 18 234
published abstracts is subsequently retracted because of real or
suspected misconduct. Rather than “terrifyingly common,” in
a world where bankers, journalists, politicians, parliamentarians,
police officers, and security agencies have been called to account
for misconduct, the rate for health scientists seems refreshingly
small.
But the retraction rate has increased 10-fold since the 1970s.
Why? Misconduct is easier to track with electronic publication,
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but pressure has also increased on researchers to publish quickly
and with as much impact as possible to ensure ongoing funding
and academic promotion. And we now have an index for an
individual’s research productivity and impact that does not
escape employers and promotion committees and national
research review exercises.20

In 35 years of attending international conferences I have seen
their form change from reasonable attempts to exchange ideas
to glitzy marketing and revenue generating exercises dominated
by industry. “Celebrity” speakers jet in, present overviews
without discussion in large plenary sessions, and jet out, while
presentations of new science or the substance of research
shrinks, with less opportunity for discussion. Form seems to
have become increasingly important at the expense of substance.
It’s hardly surprising then that a small proportion of researchers
cheat on the substance to obtain the form.

Criminalisation will not help
Biomedical research misconduct of course causes harm. But
would inviting the police to investigate more satisfactorily
uncover misconduct or prevent harm? It seems unlikely.
Consider the now infamous retracted paper on the MMR
(measles, mumps, and rubella) vaccine.21 It is the most cited
case of misconduct (758 citations at June 2012) and centred on
a case series of just 12 children.1 The misconduct—consisting
of incorrect case definitions and laboratory results, lack of
appropriate ethical review, and serious conflicts of interest—
was exposed by a journalist.22 Would the threat of criminal
proceedings have deterred publication? It seems unlikely: the
approach of discrediting one vaccine to promote a potentially
lucrative alternative suggests a mindset far beyond the concerns
of the threat of prosecution. And who exactly would have called
the cops and when?
At the other end of the scale are Yoshitaka Fujii’s 172 fraudulent
publications (of a total of 249) over 19 years, many with
fabricated data on postoperative nausea and vomiting.23 The
only motive here seems to have been publish or perish. His
coauthors were unaware of the fraud; indeed some were unaware
they were coauthors. This is really the heart of this issue. It
behoves everyone involved in research, from university vice
chancellors or institute chief executives to journal editors,
coauthors, and research staff, to be aware of what is or what is
not going on around them, with appropriate pathways for
concerns to be aired and appropriately investigated.

O’Neill argues that growing bureaucratised accountability
hampers rather than promotes trust and that a more intelligent
approach is required based on reliable and verifiable
information. In hindsight, the sources of funding and case
histories of the 12 children could easily have been verified in
the MMR paper; there were 13 authors to do it.21 It is surely not
beyond the expertise of research organisations and their staff
to reduce opportunities for misconduct, encourage open and
verifiable information on which trust can be built, investigate
appropriately, and correct misconduct in almost all its flavours.
The UK Research Integrity Office (www.ukrio.org) and the US
Office of Research Integrity (http://ori.hhs.gov) help researchers
and organisations to deal with misconduct.

What happens when the police and the judiciary do get involved?
Ask the Italian seismologists convicted of manslaughter and
given six year jail terms and hefty fines for failing to predict an
earthquake.24 Here the definitions of misconduct or fraud are
irrelevant: they didn’t commit any. Criminalising research
misconduct is a sad, bad, even mad idea that will only undermine
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the trust that is an essential component of research and requires
good governance not criminal investigators.
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